Pain News and Research

Latest Pain News and Research

Study: Toddlers living in socially-deprived areas are at greatest risk of scald

Toddlers living in socially-deprived areas are at the greatest risk of suffering a scald in the home, researchers at The University of Nottingham have found. The study, published in the journal Burns, showed that boys aged between one and two years old and those with multiple siblings were statistically more likely to suffer a hot water-related injury, while children born to mothers aged 40 years and over were at less risk than those with teenage mums.

10 May 2013

Nutritional supplement may improve survival rates of babies born with heart defects

A common nutritional supplement may be part of the magic in improving the survival rates of babies born with heart defects, researchers report. Carnitine, a compound that helps transport fat inside the cell powerhouse where it can be used for energy production, is currently used for purposes ranging from weight loss to chest pain.

10 May 2013

DURECT: Pfizer provides update on investigational drug Remoxy

DURECT Corporation today announced that Pfizer has provided an update on Remoxy as part of their Form 10-Q filing.

10 May 2013

NINDS Director affirms NIH's committed to support pain research at APS meeting

In her keynote address to the 32nd American Pain Society Annual Scientific Conference, Story Landis, PhD, director of the National Institute for Neurological Disorders and Stroke, told the APS audience that NIH is committed to research to improve understanding of the biological basis of pain and the development of effective treatments.

10 May 2013

Headline results of Creabilis' CT327 Phase 2b trial in psoriasis patients announced

Creabilis, a late stage European dermatology company with a focus on chronic pruritus (itch), today announces headline results of its Phase 2b trial with its lead product, CT327, in psoriasis patients.

10 May 2013

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

Novartis announced that the US Food and Drug Administration has approved Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis in patients aged 2 years and older.

10 May 2013

InSite Vision starts patient enrollment in confirmatory Phase 3 clinical trial of BromSite

InSite Vision Incorporated today announced that patient enrollment has begun in the confirmatory Phase 3 clinical trial of BromSite (ISV-303) for the reduction of inflammation and pain after cataract surgery.

10 May 2013

Nearly 1/10 stroke patients suffer from chronic and debilitating pain

Nearly 1 in 10 stroke patients suffer chronic and debilitating pain, typically described as sharp, stabbing or burning. It's called central poststroke pain syndrome (CPSP). It was first described more than 100 years ago, and it is treatable with medications and magnetic or electrical stimulation of the brain.

9 May 2013

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that the European Patent Office has issued a notice of Intention to Grant a European Patent that provides protection for the Company's PENNSAID 2% product.

9 May 2013

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Trevena, Inc., a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein coupled receptor biased ligands, and Forest Laboratories Holding Limited, a subsidiary of Forest Laboratories Inc., an international pharmaceutical company, announced today that they have entered into a collaborative licensing option agreement for the development of TRV027, an AT1R biased-ligand that recently completed Phase 2a clinical trials.

9 May 2013

UA researchers discover genetic mutations that cause severe epilepsies in children

Researchers at the University of Arizona have successfully determined the genetic mutations causing severe epilepsies in seven out of 10 children for whom the cause of the disorder could not be determined clinically or by conventional genetic testing.

9 May 2013

Using copper IUD or coil does not exacerbate period pain, reveals study

Using a copper intrauterine device (IUD), or coil, does not exacerbate period pain, reveals a study where researchers from the Sahlgrenska Academy, University of Gothenburg, Sweden, followed 2,100 women for 30 years.

8 May 2013

POZEN announces revenue of $1.4 million for first quarter 2013

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the first quarter ended March 31, 2013.

8 May 2013

Heart Rhythm Society launches Citywide Awareness Campaign in Denver about cardiac arrhythmia

Colorado Governor John W. Hickenlooper has proclaimed May to be Cardiac Arrhythmia Awareness Month (#RhythmAwareness), calling attention to the need for greater public awareness throughout the State about two serious heart rhythm disorders, atrial fibrillation (also known as AF or AFib) and sudden cardiac arrest (also known as SCA).

8 May 2013

Study reports that less-invasive option for spinal stenosis poses 'trade-off' in outcomes

Interspinous spacer implantation-a less-invasive alternative surgical option for spinal stenosis-has a lower complication rate than spinal fusion, reports a study in the May 1 issue of Spine The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

8 May 2013

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain is caused by lesion or disease to the peripheral somatosensory nervous system. Nerve damage that can lead to peripheral neuropathic pain can happen as a result of a range of different diseases, medications or traumatic injuries.

8 May 2013

Viewpoints: Medicaid's effect on health debated; Young adults central to lowering anxiety about online marketplaces

A study comparing low-income people in Oregon who received access to Medicaid over the past two years with those who did not, found that those on Medicaid visited doctors and hospitals more often, suffered less from depression and were more financially secure.

8 May 2013

New guidelines to help health care professionals improve care near the end of life

People with chronic or life-threatening illnesses often experience problems with their care, including confusion and conflict over how to make good decisions, poor communication with care providers, inadequate pain and symptom relief, and treatments with little or no benefit. Poor care decreases patients' quality of life, increases family stress, and adds cost but not value to health care, often with heartbreaking financial consequences for families.

8 May 2013

Study investigates use of sublingual immunotherapy against ragweed allergy

An international team of researchers, led by physician-scientists at Johns Hopkins, reports that a once-daily tablet containing a high dose of a key ragweed pollen protein effectively blocks the runny noses, sneezes, nasal congestion and itchy eyes experienced by ragweed allergy sufferers.

8 May 2013

St. Louis College of Pharmacy, DEA partner to safely dispose of unwanted medication

Rain did not hold back anyone in St. Louis looking to safely dispose of unwanted and expired medication. On April 27, a record 16,311 pounds of medication from the St. Louis metropolitan area was discarded as part of the St. Louis Medication Disposal Initiative.

8 May 2013

Pain News and Research

Latest Pain News and Research

Study: Toddlers living in socially-deprived areas are at greatest risk of scald

Nutritional supplement may improve survival rates of babies born with heart defects

DURECT: Pfizer provides update on investigational drug Remoxy

NINDS Director affirms NIH's committed to support pain research at APS meeting

Headline results of Creabilis' CT327 Phase 2b trial in psoriasis patients announced

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

InSite Vision starts patient enrollment in confirmatory Phase 3 clinical trial of BromSite

Nearly 1/10 stroke patients suffer from chronic and debilitating pain

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

UA researchers discover genetic mutations that cause severe epilepsies in children

Using copper IUD or coil does not exacerbate period pain, reveals study

POZEN announces revenue of $1.4 million for first quarter 2013

Heart Rhythm Society launches Citywide Awareness Campaign in Denver about cardiac arrhythmia

Study reports that less-invasive option for spinal stenosis poses 'trade-off' in outcomes

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Viewpoints: Medicaid's effect on health debated; Young adults central to lowering anxiety about online marketplaces

New guidelines to help health care professionals improve care near the end of life

Study investigates use of sublingual immunotherapy against ragweed allergy

St. Louis College of Pharmacy, DEA partner to safely dispose of unwanted medication

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in